183 related articles for article (PubMed ID: 32251440)
21. Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study.
Erem C; Hacihasanoglu A; Deger O; Kocak M; Topbas M
Endocrine; 2008; 34(1-3):36-51. PubMed ID: 19003544
[TBL] [Abstract][Full Text] [Related]
22. Twenty-first century epidemiology of dyslipidemia in Greece: EMENO national epidemiological study.
Stergiou GS; Ntineri A; Menti A; Kalpourtzi N; Vlachopoulos C; Liberopoulos EN; Rallidis L; Richter D; Gavana M; Vantarakis A; Chlouverakis G; Hajichristodoulou C; Trypsianis G; Voulgari PV; Alamanos Y; Karakosta A; Touloumi G
Hellenic J Cardiol; 2023; 69():1-8. PubMed ID: 36243397
[TBL] [Abstract][Full Text] [Related]
23. [Epidemiological characteristics of dyslipidemia in remote rural areas of Xinjiang, 2009-2010].
Wang YL; Yan YZ; He J; Ma JL; Zhang M; ; Zhang JY; Liu JM; Li SG; Niu Q; Rui DS; Ma RL; Guo H; Ding YS; Guo SX
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Nov; 50(11):996-1000. PubMed ID: 27916084
[No Abstract] [Full Text] [Related]
24. Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Toft N; Birgens H; Abrahamsson J; Griškevičius L; Hallböök H; Heyman M; Klausen TW; Jónsson ÓG; Palk K; Pruunsild K; Quist-Paulsen P; Vaitkeviciene G; Vettenranta K; Asberg A; Helt LR; Frandsen T; Schmiegelow K
Eur J Haematol; 2016 Feb; 96(2):160-9. PubMed ID: 25867866
[TBL] [Abstract][Full Text] [Related]
25. L-Asparaginase and steroids-associated hypertriglyceridemia successfully treated with plasmapheresis in a child with acute lymphoblastic leukemia.
Solano-Páez P; Villegas JA; Colomer I; Gutierrez MD; Fernandez-Teijeiro A
J Pediatr Hematol Oncol; 2011 Apr; 33(3):e122-4. PubMed ID: 21399528
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and factors associated with dyslipidemia in Bangladeshi adults.
Ali N; Samadder M; Kathak RR; Islam F
PLoS One; 2023; 18(1):e0280672. PubMed ID: 36662845
[TBL] [Abstract][Full Text] [Related]
27. Combined dyslipidemia in obese children: response to a focused lifestyle approach.
Pratt RE; Kavey RE; Quinzi D
J Clin Lipidol; 2014; 8(2):181-6. PubMed ID: 24636177
[TBL] [Abstract][Full Text] [Related]
28. Combination therapy of omega-3 fatty acids and acipimox for children with hypertriglyceridemia and acute lymphoblastic leukemia.
Salvador C; Entenmann A; Salvador R; Niederwanger A; Crazzolara R; Kropshofer G
J Clin Lipidol; 2018; 12(5):1260-1266. PubMed ID: 30055974
[TBL] [Abstract][Full Text] [Related]
29. Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia.
Bhojwani D; Darbandi R; Pei D; Ramsey LB; Chemaitilly W; Sandlund JT; Cheng C; Pui CH; Relling MV; Jeha S; Metzger ML
Eur J Cancer; 2014 Oct; 50(15):2685-94. PubMed ID: 25087182
[TBL] [Abstract][Full Text] [Related]
30. The relationship between dyslipidemia and inflammation among adults in east coast China: A cross-sectional study.
Hong N; Lin Y; Ye Z; Yang C; Huang Y; Duan Q; Xie S
Front Immunol; 2022; 13():937201. PubMed ID: 36032093
[TBL] [Abstract][Full Text] [Related]
31. Blood lipid profiles in children with acute lymphoblastic leukemia.
Halton JM; Nazir DJ; McQueen MJ; Barr RD
Cancer; 1998 Jul; 83(2):379-84. PubMed ID: 9669823
[TBL] [Abstract][Full Text] [Related]
32. Lipid Profile and the Frequency of Dyslipidemia in Iranian Adolescents with Severe Obesity, Who Were Candidates for Bariatric Surgery.
Soheilipour F; Geram F
Obes Surg; 2024 Feb; 34(2):618-624. PubMed ID: 38191967
[TBL] [Abstract][Full Text] [Related]
33. Association of serum BPA levels with changes in lipid levels and dyslipidemia risk in middle-aged and elderly Chinese.
Yao J; Wang F; Zhang Y; Zhang Z; Bi J; He J; Li P; Han X; Wei Y; Zhang X; Guo H; He M
Ecotoxicol Environ Saf; 2022 Aug; 241():113819. PubMed ID: 36068747
[TBL] [Abstract][Full Text] [Related]
34. Early changes of blood lipid levels during psychotropic drug treatment as predictors of long-term lipid changes and of new onset dyslipidemia.
Delacrétaz A; Vandenberghe F; Gholam-Rezaee M; Saigi Morgui N; Glatard A; Thonney J; Solida-Tozzi A; Kolly S; Gallo SF; Baumann P; Berney S; Zulauff SV; Aubry JM; Hasler R; Ebbing K; von Gunten A; Conus P; Eap CB
J Clin Lipidol; 2018; 12(1):219-229. PubMed ID: 29128242
[TBL] [Abstract][Full Text] [Related]
35. Frequency of secondary dyslipidemia in obese children.
Korsten-Reck U; Kromeyer-Hauschild K; Korsten K; Baumstark MW; Dickhuth HH; Berg A
Vasc Health Risk Manag; 2008; 4(5):1089-94. PubMed ID: 19183757
[TBL] [Abstract][Full Text] [Related]
36. Severe drug-induced hypertriglyceridemia treated with plasmapheresis in children with acute lymphoblastic leukemia.
Zawitkowska J; Lejman M; Zaucha-Prażmo A; Sekuła N; Greczkowska-Chmiel T; Drabko K
Transfus Apher Sci; 2019 Oct; 58(5):634-637. PubMed ID: 31515171
[TBL] [Abstract][Full Text] [Related]
37. Prolonged first-line PEG-asparaginase treatment in pediatric acute lymphoblastic leukemia in the NOPHO ALL2008 protocol-Pharmacokinetics and antibody formation.
Tram Henriksen L; Gottschalk Højfeldt S; Schmiegelow K; Frandsen TL; Skov Wehner P; Schrøder H; Klug Albertsen B;
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28660740
[TBL] [Abstract][Full Text] [Related]
38. Results of retrospective chart review to determine improvement in lipid goal attainment in patients treated by high-volume prescribers of lipid-modifying drugs.
Stacy TA; Egger A
J Manag Care Pharm; 2006; 12(9):745-51. PubMed ID: 17249907
[TBL] [Abstract][Full Text] [Related]
39. [Successful readministration of L-asparaginase after development of severe hypertriglyceridemia in a young adult with T-cell acute lymphoblastic leukemia].
Watanabe K; Yoshifuji K; Ohkawa R; Tozuka M; Miura O; Arai A
Rinsho Ketsueki; 2018; 59(12):2555-2560. PubMed ID: 30626788
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of dyslipidemia and its associated factors among university academic staff and students in Bangladesh.
Ali N; Kathak RR; Fariha KA; Taher A; Islam F
BMC Cardiovasc Disord; 2023 Jul; 23(1):366. PubMed ID: 37479968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
